Jack A. Khattar - Mar 14, 2022 Form 4/A - Amendment Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: President, CEO, Director
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Stock symbol: SUPN
Transactions as of: Mar 14, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 1/13/2023, 04:00 PM
Date Of Original Report: Mar 17, 2022
Previous filing: Feb 24, 2022
Next filing: Mar 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SUPN	Common Stock	Options Exercise	$0	+40K	+7.74%	$0.00	556K	Mar 14, 2022	Direct	F1
transaction	SUPN	Common Stock	Award	$0	+20K	+3.59%	$0.00	576K	Mar 14, 2022	Direct	F1
holding	SUPN	Common Stock						1.06M	Mar 14, 2022	By the KBT Trust
holding	SUPN	Common Stock						4K	Mar 14, 2022	By Son	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Performance Share Unit	Options Exercise	$0	-40K	-100%	$0.00^*	0	Mar 14, 2022	Common Stock	40K	$0.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 19, 2021.
F2	The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
F3	On February 19, 2021, the Reporting Person was awarded Performance Shares Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.